In recent weeks there has been concern and considerable media speculation surrounding the vaccine supply chain, largely in relation to the availability of glass vials to contain the vaccine before injections are administered.
British Glass CEO Dave Dalton comments:
“British Glass is in continuous dialogue with the full vaccine supply chain, relevant trade bodies and the government to both gain an understanding into the current situation and advise appropriately to ensure capacity in the UK.
“Unfortunately, part of the speculation at issue is down to a lack of public knowledge – not understanding the nature of the vials required for the vaccine roll-out, the manufacture of said vials and more critically what is available on the market or already secured by order.
“Part of this information is also hard to come by due its commercially sensitive nature, which is why it is important to work collaboratively to understand the full picture and not plug the gaps in knowledge with misinformation.
“Due to the swift nature of developing the Covid vaccines, this is a rapidly moving situation and whilst it is important to look at the immediate needs in supply, British Glass is also addressing and assessing possible long-term solutions such as UK borosilicate glass production.”
Whilst the situation continues to develop, British Glass will provide an update weekly.
15.01.2021, British Glass
此网站新闻材料的版权属于公司或第三方的新闻提供者，其所有权利保留。所有新闻材料对其访问者只能限于其本人使用，并且使用此材料的风险由其使用者独自自行承担。严禁对新闻材料进行再次发布和其它商业利用. 作为商业贸易的用途。如果新闻材料由第三方提供，当应用此新闻材料时，每个使用者都同意遵守，并且受此特定的项目的约束。Glass Global并不代表及认可新闻材料中所包含的内容及新闻中的外部网站的内容的准确性及可靠性。
Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.